Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

SalioGen Therapeutics

Company Type: Therapeutic development

Main focus: Developing new therapeutics using their novel Gene Coding™ technology

Company stage: Pre-clinical

Diseases: Diseases of the eye/retina, ears, lungs, brain/CNS, and certain cancers

Genome-editing tool: Saliogase™ enzyme

Funding stage: Series B

Location: Lexington, Massachusetts, USA

Website: https://www.saliogen.com/

Pipeline: https://www.saliogen.com/pipeline/

Partners:

SalioGen Therapeutics is a biotechnology company that focuses on developing advanced gene therapy solutions. They specialise in a proprietary platform called Gene Coding™, which aims to provide durable and safe treatments for a variety of genetic diseases through insertion of large or multiple whole genes into the genome at specific locations via transposition using a bioengineered enzyme, Saliogase™.

Tags

HashtagSalioGen Therapeutics

Company: SalioGen Therapeutics
close
Search CRISPR Medicine